Table 1.
Genotype | Relative FRUM immunostaining, % (n pupal CNS specimens) |
---|---|
WT | 100 (10) |
fru3/fru3 | 0 (6) |
fruw12/fru3 | 0 (3) |
Df-fruw24/fru3 | 0 (5) |
fruw27/fru3 | 0 (5) |
fru3/Df-ChaM5 | 0 (7) |
fruw12/Df-ChaM5 | 0 (7) |
fruw27/Df-ChaM5 | 0 (5) |
fruw12/Df-fruw24 | 0 (3) |
fruw12/fruw27 | 0 (3) |
Df-fruw24/fruw27 | 0 (3) |
Df-ChaM5/Df-sat15 | 0 (5) |
Df-fru4-40/Df-sat15 | 0 (5) |
Immunohistochemistry using anti-FRUM was performed to assess expression of the male forms of FRU protein in the CNSs of 2-d-old male pupae from a wild-type (WT) stock, afru3-bearing strain, and pupal progeny resulting from crosses of fru-breakpoint variants to each other or certain such variants to fru3 (the only homozygous-viable mutant used here). The w-including genotypes are chromosome aberrations, each involving a breakpoint within the fru locus; most of the Df-including genotypes are deletions, each of which has one breakpoint at this locus and thus is missing part of the locus (Df-fruw24removes the entire locus). Nearly all breakpoint combinations, with respect to the chromosome aberrations depicted in Figure 1, were generated, except forfruw24/Df-ChaM5 (which die as embryos). For the results column, the wild-type staining level was simply set at 100, because there was no apparent FRUMimmunostaining in pupae carrying any of these mutant orfru-breakpoint variant specimens.